Search This Blog

Thursday, November 21, 2019

Enanta Pharma EPS misses by $0.12, misses on revenue

Enanta Pharma (NASDAQ:ENTA): Q4 GAAP EPS of $0.44 misses by $0.12.
Revenue of $51.31M (-23.7% Y/Y) misses by $4.64M.
Shares -2.74%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)